The TMEM43 Newfoundland mutation p.S358L causing ARVC-5 was imported from Europe and increases the stiffness of the cell nucleus
- PMID: 24598986
- DOI: 10.1093/eurheartj/ehu077
The TMEM43 Newfoundland mutation p.S358L causing ARVC-5 was imported from Europe and increases the stiffness of the cell nucleus
Abstract
Aims: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a rare genetic condition caused predominantly by mutations within desmosomal genes. The mutation leading to ARVC-5 was recently identified on the island of Newfoundland and caused by the fully penetrant missense mutation p.S358L in TMEM43. Although TMEM43-p.S358L mutation carriers were also found in the USA, Germany, and Denmark, the genetic relationship between North American and European patients and the disease mechanism of this mutation remained to be clarified.
Methods and results: We screened 22 unrelated ARVC patients without mutations in desmosomal genes and identified the TMEM43-p.S358L mutation in a German ARVC family. We excluded TMEM43-p.S358L in 22 unrelated patients with dilated cardiomyopathy. The German family shares a common haplotype with those from Newfoundland, USA, and Denmark, suggesting that the mutation originated from a common founder. Examination of 40 control chromosomes revealed an estimated age of 1300-1500 years for the mutation, which proves the European origin of the Newfoundland mutation. Skin fibroblasts from a female and two male mutation carriers were analysed in cell culture using atomic force microscopy and revealed that the cell nuclei exhibit an increased stiffness compared with TMEM43 wild-type controls.
Conclusion: The German family is not affected by a de novo TMEM43 mutation. It is therefore expected that an unknown number of European families may be affected by the TMEM43-p.S358L founder mutation. Due to its deleterious clinical phenotype, this mutation should be checked in any case of ARVC-related genotyping. It appears that the increased stiffness of the cell nucleus might be related to the massive loss of cardiomyocytes, which is typically found in ventricles of ARVC hearts.
Keywords: Arrhythmogenic right ventricular cardiomyopathy; Cardiogenetics; Molecular genetics; Sudden cardiac death; TMEM43.
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2014. For permissions please email: journals.permissions@oup.com.
Similar articles
-
Recurrent missense mutations in TMEM43 (ARVD5) due to founder effects cause arrhythmogenic cardiomyopathies in the UK and Canada.Eur Heart J. 2013 Apr;34(13):1002-11. doi: 10.1093/eurheartj/ehs383. Epub 2012 Nov 15. Eur Heart J. 2013. PMID: 23161701
-
TMEM43 mutations associated with arrhythmogenic right ventricular cardiomyopathy in non-Newfoundland populations.Hum Genet. 2013 Nov;132(11):1245-52. doi: 10.1007/s00439-013-1323-2. Epub 2013 Jun 29. Hum Genet. 2013. PMID: 23812740
-
Clinical characteristics and determinants of the phenotype in TMEM43 arrhythmogenic right ventricular cardiomyopathy type 5.Heart Rhythm. 2020 Jun;17(6):945-954. doi: 10.1016/j.hrthm.2020.01.035. Epub 2020 Feb 13. Heart Rhythm. 2020. PMID: 32062046
-
Transmembrane Protein 43: Molecular and Pathogenetic Implications in Arrhythmogenic Cardiomyopathy and Various Other Diseases.Int J Mol Sci. 2025 Jul 17;26(14):6856. doi: 10.3390/ijms26146856. Int J Mol Sci. 2025. PMID: 40725103 Free PMC article. Review.
-
Naxos disease and Carvajal syndrome: cardiocutaneous disorders that highlight the pathogenesis and broaden the spectrum of arrhythmogenic right ventricular cardiomyopathy.Cardiovasc Pathol. 2004 Jul-Aug;13(4):185-94. doi: 10.1016/j.carpath.2004.03.609. Cardiovasc Pathol. 2004. PMID: 15210133 Review.
Cited by
-
International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework.Circ Genom Precis Med. 2021 Jun;14(3):e003273. doi: 10.1161/CIRCGEN.120.003273. Epub 2021 Apr 8. Circ Genom Precis Med. 2021. PMID: 33831308 Free PMC article. Clinical Trial.
-
Atomic Force Microscopy (AFM) Applications in Arrhythmogenic Cardiomyopathy.Int J Mol Sci. 2022 Mar 28;23(7):3700. doi: 10.3390/ijms23073700. Int J Mol Sci. 2022. PMID: 35409059 Free PMC article. Review.
-
In Vivo Approaches to Understand Arrhythmogenic Cardiomyopathy: Perspectives on Animal Models.Cells. 2024 Jul 27;13(15):1264. doi: 10.3390/cells13151264. Cells. 2024. PMID: 39120296 Free PMC article. Review.
-
TMEM-ing the Tide: Gene Therapy Holds Promise for ARVC5.Circ Res. 2025 Apr 11;136(8):845-847. doi: 10.1161/CIRCRESAHA.125.326367. Epub 2025 Apr 10. Circ Res. 2025. PMID: 40208928 No abstract available.
-
Cardiac MRI and Clinical Outcomes in TMEM43 Arrhythmogenic Cardiomyopathy.Radiol Cardiothorac Imaging. 2023 Dec;5(6):e230155. doi: 10.1148/ryct.230155. Radiol Cardiothorac Imaging. 2023. PMID: 38166344 Free PMC article.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous